Correlation Between Mereo BioPharma and CTi Biopharma
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and CTi Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and CTi Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and CTi Biopharma Corp, you can compare the effects of market volatilities on Mereo BioPharma and CTi Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of CTi Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and CTi Biopharma.
Diversification Opportunities for Mereo BioPharma and CTi Biopharma
-0.42 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Mereo and CTi is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and CTi Biopharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CTi Biopharma Corp and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with CTi Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CTi Biopharma Corp has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and CTi Biopharma go up and down completely randomly.
Pair Corralation between Mereo BioPharma and CTi Biopharma
If you would invest 335.00 in Mereo BioPharma Group on August 25, 2024 and sell it today you would earn a total of 37.00 from holding Mereo BioPharma Group or generate 11.04% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 0.79% |
| Values | Daily Returns |
Mereo BioPharma Group vs. CTi Biopharma Corp
Performance |
| Timeline |
| Mereo BioPharma Group |
| CTi Biopharma Corp |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Mereo BioPharma and CTi Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and CTi Biopharma
The main advantage of trading using opposite Mereo BioPharma and CTi Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, CTi Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CTi Biopharma will offset losses from the drop in CTi Biopharma's long position.| Mereo BioPharma vs. Eliem Therapeutics | Mereo BioPharma vs. HCW Biologics | Mereo BioPharma vs. RenovoRx | Mereo BioPharma vs. Scpharmaceuticals |
| CTi Biopharma vs. Rigel Pharmaceuticals | CTi Biopharma vs. Fortress Biotech | CTi Biopharma vs. Reviva Pharmaceuticals Holdings | CTi Biopharma vs. Protalix Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |